Genomma Lab Internacional SAB de CV (LABB):企業の財務・戦略的SWOT分析

◆英語タイトル:Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2911
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Genomma Lab Internacional SAB de CV (LABB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomma Lab Internacional SAB de CV (Genomma Lab) carries out the research, manufacture and commercialization of pharmaceuticals and other healthcare products. Its product portfolio includes wellness products, personal care products, dermo-cosmetic products and other halthcare products. The company offers anti-acne products, scar removal ointments, anti-acids, varicose vein treatments, analgesics, anti-fungal products, anti-inflammatory products, multivitamins, hemorrhoid treatments, colitis treatment products, shampoos, flu treatments and others. Genomma Lab also conducts research and development of drugs and personal care products to ensure safety, efficacy and quality of all its brands. It offers its products in Mexico, Latin America and the US. Genomma Lab is headquartered at Mexico City, Mexico.

Genomma Lab Internacional SAB de CV Key Recent Developments

Jul 25,2018: Genomma Lab Internacional reports second quarter 2018 results
Apr 25,2018: Genomma Lab Internacional Reports First Quarter 2018 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Genomma Lab Internacional SAB de CV – Key Facts 5
Genomma Lab Internacional SAB de CV – Key Employees 6
Genomma Lab Internacional SAB de CV – Major Products and Services 7
Genomma Lab Internacional SAB de CV – History 9
Genomma Lab Internacional SAB de CV – Company Statement 11
Genomma Lab Internacional SAB de CV – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Genomma Lab Internacional SAB de CV – Business Description 14
Genomma Lab Internacional SAB de CV – SWOT Analysis 15
SWOT Analysis – Overview 15
Genomma Lab Internacional SAB de CV – Strengths 15
Genomma Lab Internacional SAB de CV – Weaknesses 16
Genomma Lab Internacional SAB de CV – Opportunities 17
Genomma Lab Internacional SAB de CV – Threats 18
Genomma Lab Internacional SAB de CV – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Genomma Lab Internacional SAB de CV, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Jul 25, 2018: Genomma Lab Internacional reports second quarter 2018 results 30
Apr 25, 2018: Genomma Lab Internacional Reports First Quarter 2018 Results 31
Section 6 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Genomma Lab Internacional SAB de CV, Key Facts 5
Genomma Lab Internacional SAB de CV, Key Employees 6
Genomma Lab Internacional SAB de CV, Major Products and Services 7
Genomma Lab Internacional SAB de CV, History 9
Genomma Lab Internacional SAB de CV, Subsidiaries 12
Genomma Lab Internacional SAB de CV, Key Competitors 19
Genomma Lab Internacional SAB de CV, Ratios based on current share price 20
Genomma Lab Internacional SAB de CV, Annual Ratios 21
Genomma Lab Internacional SAB de CV, Annual Ratios (Cont...1) 22
Genomma Lab Internacional SAB de CV, Annual Ratios (Cont...2) 23
Genomma Lab Internacional SAB de CV, Interim Ratios 25
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Genomma Lab Internacional SAB de CV, Recent Deals Summary 29
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
Genomma Lab Internacional SAB de CV, Performance Chart (2013 - 2017) 24
Genomma Lab Internacional SAB de CV, Ratio Charts 26
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[Genomma Lab Internacional SAB de CV (LABB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mekonomen AB:企業の戦略・SWOT・財務情報
    Mekonomen AB - Strategy, SWOT and Corporate Finance Report Summary Mekonomen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • SANUWAVE Health Inc (SNWV):企業の財務・戦略的SWOT分析
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company's products portfolio include dermapace, which is used in the treatment of chronic and acute conditi …
  • Husky Energy Inc (HSE):石油・ガス:M&Aディール及び事業提携情報
    Summary Husky Energy Inc (Husky) is an integrated energy company. It operates across the oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bitumen, natural gas and natural gas liquids (NGL). Its midstream operations include pipeline tr …
  • Belvedere International Inc.:企業の戦略・SWOT・財務情報
    Belvedere International Inc. - Strategy, SWOT and Corporate Finance Report Summary Belvedere International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • Ultra Petroleum Corp.:企業の戦略・SWOT・財務分析
    Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report Summary Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Brazil Fast Food Corp.:企業の戦略・SWOT・財務情報
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Construcciones y Auxiliar de Ferrocarriles SA:企業の戦略・SWOT・財務情報
    Construcciones y Auxiliar de Ferrocarriles SA - Strategy, SWOT and Corporate Finance Report Summary Construcciones y Auxiliar de Ferrocarriles SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Basware Oyj (BAS1V):企業の財務・戦略的SWOT分析
    Basware Oyj (BAS1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Air T Inc:企業の戦略・SWOT・財務分析
    Air T Inc - Strategy, SWOT and Corporate Finance Report Summary Air T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • CeraPedics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CeraPedics Inc (Cerapedics) is a medical device company that develops and commercializes novel osteobiologic products. The company’s products include i-factor putty, a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to i …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Lahey Hospital and Medical Center:企業の戦略的SWOT分析
    Lahey Hospital and Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • TransMontaigne Partners LP (TLP):企業の財務・戦略的SWOT分析
    Summary TransMontaigne Partners LP (TLP), a subsidiary of TransMontaigne GP LLC is an energy infrastructure service provider that offers integrated terminaling, transportation, and storage services. The company distributes and transports crude oil, chemicals, petroleum products, fertilizers, and oth …
  • Cyxone AB-製薬・医療分野:企業M&A・提携分析
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company’s lead product include T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務分析
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Mizuno Corporation (8022):企業の財務・戦略的SWOT分析
    Mizuno Corporation (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Duke Energy Corporation:企業の戦略・SWOT・財務情報
    Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TOP Ships Inc. (TOPS):企業の財務・戦略的SWOT分析
    TOP Ships Inc. (TOPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆